Aquestive therapeutics reports third quarter 2023 financial results and provides business update

Warren, n.j., nov. 06, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today reported financial results for the third quarter ended september 30, 2023 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking